Breaking News

CoreRx Completes Acquisition of Societal CDMO

Societal CDMO is now a wholly-owned subsidiary of CoreRx.

Author Image

By: Charlie Sternberg

Associate Editor

CoreRx Inc. has completed its previously announced $130 million acquisition of Societal CDMO Inc., a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily focused on small molecule therapeutics.   As a result of the merger, Societal CDMO is now a wholly-owned subsidiary of CoreRx.   According to David Enloe, CEO of Societal CDMO, the enhanced CDMO created through this transaction will be positioned to offer both ex...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters